The ‘basics’ of viral hepatitis
Hepatitis refers to an inflammation of the liver, which can be caused, amongst other things, by hepatitis viruses. The most widely known forms are hepatitis A, hepatitis B and hepatitis C. Hepatitis A is most commonly transmitted through contaminated water or by consuming infected food, such as mussels, and usually leads to a harmless acute inflammation of the liver accompanied by nausea, vomiting or diarrhoea. Hepatitis B and C viruses are primarily transmitted via the blood, for example through needles (intravenous drug use, tattoos or piercings, etc.) or via transfusions of blood products prior to 1991. Hepatitis B (and, more rarely, hepatitis C) can also be transmitted sexually. Hepatitis B and C usually lead to chronic inflammation of the liver (chronic hepatitis), with the serious consequences of developing cirrhosis of the liver and an increased risk of liver cancer; they are responsible for a very high number of deaths worldwide. Only people who also have hepatitis B can contract hepatitis D. A new, widespread but as yet little-noticed virus is the hepatitis E virus.
Hepatitis E – an underestimated danger
The hepatitis E virus is found worldwide and causes inflammation of the liver. For a long time, hepatitis E was regarded primarily as a travel-related or tropical disease, predominantly found in Africa and Asia. However, we now know that hepatitis E is also very widespread in Europe. According to current infection figures (from Austria and Germany), hepatitis E is now the most common form of acute viral hepatitis. The latest annual statistics from the Robert Koch Institute (RKI) showed a significant increase in reported cases (in Germany, approximately 2,000 cases per year). Scientific studies have shown that the seroprevalence in the population (the proportion of people carrying antibodies against the virus) is around 20 per cent, and in some regions as high as 30 per cent. This means that one in five people, and in some cases even one in three, have had contact with the hepatitis E virus at some point. In any case where there is an unexplained rise in liver enzyme levels, your doctor should therefore also test for hepatitis E. In tropical and subtropical countries in Africa and Asia, as well as in South America, where hepatitis E virus genotypes 1 and 2 are present, poor hygiene and contaminated drinking water are the main routes of transmission. Here, however, where genotype 3 of the virus is prevalent, the virus is transmitted primarily through the consumption of raw or undercooked pork. A study of domestic pigs and wild boar in Austria showed that the hepatitis E virus was detected in 6 per cent and 23 per cent, respectively, of all meat samples tested. However, other foods – particularly game, hare, mussels, strawberries and the highly sought-after seaweed (wakame) – can also act as vectors for the infection. Heating to over 70 degrees for a period of at least 10 minutes kills the virus. People with a weakened immune system should be particularly careful. It is advisable to avoid eating meat products that are not sufficiently cooked or thoroughly cooked through; these include raw sausages, liver sausage, and smoked or cured pork or game products.
Hepatitis: People with weakened immune systems are at risk
In the majority of those infected, hepatitis E presents as a silent and almost unnoticeable (largely asymptomatic) infection of the liver. In a small proportion of those affected, however, it may also be accompanied by acute hepatitis (yellowing of the eyes and skin, abdominal pain, and possibly fever and fatigue). In healthy people with a fully functioning immune system, this inflammation usually resolves on its own and does not require any specific treatment. However, only a small proportion of those affected – primarily older men or patients with pre-existing liver disease – may develop very severe hepatitis, which can progress to acute liver failure. The situation is entirely different for patients with chronic immunodeficiency (congenital or acquired), such as those with HIV, patients requiring chemotherapy, or those who must take specific medication (immunosuppressants) following an organ transplant or due to severe rheumatic disease. Immunocompromised patients are at very high risk (up to 50 per cent) of developing chronic inflammation of the liver, which can lead to cirrhosis, liver cancer and, ultimately, death. By definition, a chronic hepatitis E infection is diagnosed when the virus remains detectable in the body for a period of at least three months. In such cases, referral to a recognised specialist in liver diseases, as well as immediate treatment and monitoring, is indicated.
Drug therapy is possible
Although no specific drug therapy has yet been authorised for the treatment of hepatitis E, treatment of chronic hepatitis E is possible and should under no circumstances be delayed. On the one hand, an attempt can be made to slightly reduce immunosuppressive therapy – that is, the deliberate suppression of the immune system – so that the body itself has a chance to fight off the virus and keep it at bay. Alternatively, a drug (ribavirin), which we are familiar with from hepatitis C treatment, can be administered as an ‘off-label treatment’. Treatment with ribavirin, which usually lasts several weeks, leads to a cure for chronic hepatitis E in up to approximately 90 per cent of cases. A vaccine against hepatitis E has been available since 2011, but it is only authorised in China. It also remains unclear whether the vaccine is effective against the strain (genotype) of the virus prevalent here.
Virus also replicates outside the liver
It has only recently been demonstrated that hepatitis E viruses can also replicate outside the liver. This may also depend on the genotype and thus the respective geographical region: hepatitis E virus genotype 1, which is predominantly found in Asia, appears to be associated with the occurrence of pancreatitis (inflammation of the pancreas). Genotype 3, which is prevalent in Europe, is associated with neurological disorders such as Guillain–Barré syndrome, a rare form of nerve inflammation (polyradiculitis), or neuralgic shoulder amyotrophy, a paralysis of the shoulder and arm muscles. The virus, which replicates primarily in the liver and is excreted via the bile, can usually be detected in the blood and also in the stools of those affected. In a recent study, we were also able to detect the virus for the first time in the ejaculate of chronically infected men, and in much higher quantities than in the blood. This is of particular interest in that the testicles could represent a refuge and a niche in which the viruses could hide from the immune system or remain undetected in the body for such a long time. Guest author: Dr med. univ., Dr scient. med. Thomas Horvatits, specialist in internal medicine and gastroenterology